SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
Summary
SYMPHONY will perform research on all aspects of care, treatment individualization in patients with inborn bleeding disorders as well as diagnostic innovations and results of molecular genetics and cellular model technology with regard to the hemostatic process. We believe that these research investments will lead to health care innovations with long-term clinical and societal impact. This consortium has been made possible by a governmental, competitive grant from the Netherlands Organization for Scientific Research (NWO) within the framework of the NWA-ORC Call grant agreement NWA.1160.18.038. This article is protected by copyright. All rights reserved.
| Authors | Cnossen MH, van Moort I, Reitsma SH, de Maat MPM, Schutgens REG, Urbanus RT, Lingsma HF, Mathot RAA, Gouw SC, Meijer K, Bredenoord AL, van der Graaf R, Fijnvandraat K, Meijer AB, van den Akker E, Bierings R, Eikenboom JCJ, van den Biggelaar M, de Haas M, Voorberg J, Leebeek FWG, SYMPHONY consortium |
|---|---|
| Journal | Journal of thrombosis and haemostasis : JTH |
| Publication Date | 2022 Jun 2;20(9):2001-11 |
| PubMed | 35652368 |
| PubMed Central | PMC9545335 |
| DOI | 10.1111/jth.15778 |